Geode Capital Management
CO

Geode Capital Management’s Global Cord Blood Corporation CO Stock Holding History

Geode Capital Management’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-20,751
Closed -$145K – 4255
2018
Q3 		$145K Buy
+20,751
New +$156K ﹤0.01% 3848

Other funds holding CO

JCM
Jayhawk Capital Management Shawnee, Kansas $59.9M AUM 22.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management's CO Position: Q4 2018 in Review

Geode Capital Management sold out of Global Cord Blood Corporation (CO) in Q4 2018, closing a stake of 20,751 shares — an estimated $145K sold.

Geode Capital Management first reported a position in CO in Q3 2018 and held it in 1 quarter. The position peaked at $145K in Q3 2018. 40 funds tracked by Wall St. Rank hold CO as of Q4 2018.

  • Geode Capital Management reported no remaining Global Cord Blood Corporation position as of Q4 2018 after selling out during the quarter.
  • Geode Capital Management sold 20,751 Global Cord Blood Corporation shares in Q4 2018, an estimated $145K.
  • Geode Capital Management first reported a position in Global Cord Blood Corporation in Q3 2018 and held it in 1 quarter.
  • Geode Capital Management's Global Cord Blood Corporation position peaked at $145K in Q3 2018.
  • 40 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q4 2018.

Based on Geode Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.